Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Oct 15;155(2):207-16.
doi: 10.1083/jcb.200105137. Epub 2001 Oct 8.

APAF1 is a key transcriptional target for p53 in the regulation of neuronal cell death

Affiliations

APAF1 is a key transcriptional target for p53 in the regulation of neuronal cell death

A Fortin et al. J Cell Biol. .

Abstract

p53 is a transcriptional activator which has been implicated as a key regulator of neuronal cell death after acute injury. We have shown previously that p53-mediated neuronal cell death involves a Bax-dependent activation of caspase 3; however, the transcriptional targets involved in the regulation of this process have not been identified. In the present study, we demonstrate that p53 directly upregulates Apaf1 transcription as a critical step in the induction of neuronal cell death. Using DNA microarray analysis of total RNA isolated from neurons undergoing p53-induced apoptosis a 5-6-fold upregulation of Apaf1 mRNA was detected. Induction of neuronal cell death by camptothecin, a DNA-damaging agent that functions through a p53-dependent mechanism, resulted in increased Apaf1 mRNA in p53-positive, but not p53-deficient neurons. In both in vitro and in vivo neuronal cell death processes of p53-induced cell death, Apaf1 protein levels were increased. We addressed whether p53 directly regulates Apaf1 transcription via the two p53 consensus binding sites in the Apaf1 promoter. Electrophoretic mobility shift assays demonstrated p53-DNA binding activity at both p53 consensus binding sequences in extracts obtained from neurons undergoing p53-induced cell death, but not in healthy control cultures or when p53 or the p53 binding sites were inactivated by mutation. In transient transfections in a neuronal cell line with p53 and Apaf1 promoter-luciferase constructs, p53 directly activated the Apaf1 promoter via both p53 sites. The importance of Apaf1 as a p53 target gene in neuronal cell death was evaluated by examining p53-induced apoptotic pathways in primary cultures of Apaf1-deficient neurons. Neurons treated with camptothecin were significantly protected in the absence of Apaf1 relative to those derived from wild-type littermates. Together, these results demonstrate that Apaf1 is a key transcriptional target for p53 that plays a pivotal role in the regulation of apoptosis after neuronal injury.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
p53-mediated induction of Apaf1 mRNA in neurons. (A) RNA was extracted from neurons 36 or 48 h after infection with Ad-p53 or Ad-p53-173L and analyzed for Apaf1 or GAPDH expression using semiquantitative RT-PCR. (B) RNA was extracted from wild-type or p53-deficient neurons at the indicated times after treatment with 10 μM camptothecin and analyzed for Apaf1 or GAPDH expression using semiquantitative RT-PCR.
Figure 2.
Figure 2.
p53-mediated induction of Apaf1 protein in neurons. (A) Protein was extracted from neurons 48 or 60 h after infection with Ad-p53 or Ad-p53-173L and assayed for Apaf1 levels by Western blot analysis. (B) Protein was extracted from wild-type or p53-deficient neurons at the indicated times after treatment with 10 μM camptothecin and assayed for Apaf1 levels by Western blot analysis. Specificity of the Apaf1 antibody is demonstrated by lack of immunoreactivity in extracts derived from Apaf1 knockout brain and loading is standardized with actin.
Figure 3.
Figure 3.
Induction of Apaf1 in neurons after focal ischemia in mice. Mice were subjected to 2 h of middle cerebral artery occlusion followed by 24 h of reperfusion. (A) Sections from ipsilateral and contralateral forebrain were prepared and immunostained for Apaf1. (B) Western blot analysis of Apaf1 expression in contralateral (C) versus ipsilateral (I) cortex and striatum after focal ischemia.
Figure 4.
Figure 4.
Specific binding of p53 to Apaf1 promoter elements in neuronal extracts. (A) Comparison of p53 consensus binding sequence (p53 CBS; el-Deiry et al., 1992), with two putative p53 recognition sequences located in the Apaf1 promoter (Apaf1 BS1 and BS2). The sequence of the corresponding mutated versions of these oligonucleotides (Apaf1 BS1-mut and BS2-mut) used in the electrophoretic mobility shift assays are also indicated. (B) Protein was extracted from neurons 48 h after infection with Ad-p53 or Ad-p53-173L and p53 binding activity to the Apaf1 promoter elements was assayed by electrophoretic mobility shift assay. Binding reactions were carried out with neuronal extracts (10 μg protein) and the indicated oligonucleotides in the presence of p53 antibody (pAb1). (C) Cell extracts (20 μg protein) obtained from untreated neurons or neurons exposed to camptothecin (10 μM) for 12 h were tested for p53 binding activity to the Apaf1 promoter elements as described above. (D) Specificity of p53 binding activity to the Apaf1 promoter was examined in p53+/+ and p53−/− neurons treated with camptothecin. Supershifts with two antibodies directed against p53 were carried out on p53+/+ neurons to further confirm the presence of p53 binding to the Apaf1 promoter.
Figure 5.
Figure 5.
Activation of the Apaf1 promoter by p53 in a neuronal cell line. (A) p53 responsiveness of the Apaf1 promoter was tested using luciferase reporter constructs (pGL3b; Promega) consisting of the luciferase gene fused to an Apaf1 promoter fragment containing both p53 binding sites (BS1 and BS2), or truncated promoter fragments deleted for one or both p53 recognition sequences. (B) SN48 cells were cotransfected with the indicated luciferase reporter construct, a CMV–β-gal reporter construct, and an expression plasmid for either wild-type p53, DNA binding–defective p53-173L, or empty vector as control. Luciferase activity was measured in cell lysates obtained 48 h after transfection and normalized to β-galactosidase activity. Fold increase indicates the ratio of normalized luciferase activity of each Apaf1 promoter construct in the presence of p53 expression vector versus empty vector control. Data represent the mean and standard error of triplicate samples from three independent experiments.
Figure 6.
Figure 6.
Apaf1-deficient neurons exhibit increased resistance to p53-mediated cell death. (A) Cortical neurons obtained from Apaf1-deficient mice or wild-type littermates were treated with 10 μM camptothecin and cell survival was determined by LIVE/DEAD assay (Molecular Probes) at the indicated times. Survival is reported as a percentage of corresponding untreated control cultures. Data represents the mean values obtained from independent cultures involving three separate Apaf1 knockout mice and matching wild-type littermates, and error bars indicate standard deviation of the mean. (B) Cortical neurons from Apaf1+/+ and Apaf1−/− littermates were treated with camptothecin and after 24 h neurons were stained in a LIVE/DEAD assay. Live cells exhibit positive staining for calcein AM activity (green fluorescence), whereas dead cells stain positive for ethidium homodimer (red fluorescence). Bar, 100 μm.
Figure 7.
Figure 7.
Apaf1 deficiency decreases p53-mediated apoptosis in neurons. (A) Cortical neurons obtained from Apaf1-deficient mice or wild-type littermates were treated with 10 μM camptothecin and the extent of apoptotic cell death was determined by Tunel assay. Data represents the mean and standard deviation of three independent experiments. (B) Cortical neurons from Apaf1+/+ and Apaf1−/− littermates were treated with camptothecin and after 24 h cells were fixed, stained for Tunel, and counterstained with Hoechst. Bar, 100 μm.

Similar articles

Cited by

References

    1. Banasiak, K.J., and G.G. Haddad. 1998. Hypoxia-induced apoptosis: effect of hypoxic severity and role of p53 in neuronal cell death. Brain Res. 797:295–304. - PubMed
    1. Bates, S., A.C. Phillips, P.A. Clark, F. Stott, G. Peters, R.L. Ludwig, and K.H. Vousden. 1998. p14ARF links the tumour suppressors RB and p53. Nature. 395:124–125. - PubMed
    1. Brady, H.J., G.S. Salomons, R.C. Bobeldijk, and A.J. Berns. 1996. T cells from bax alpha transgenic mice show accelerated apoptosis in response to stimuli but do not show restored DNA damage-induced cell death in the absence of p53. gene product in. EMBO J. 15:1221–1230. - PMC - PubMed
    1. Cecconi, F., G. Alvarez-Bolado, B.I. Meyer, K.A. Roth, and P. Gruss. 1998. Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development. Cell. 94:727–737. - PubMed
    1. Cheng, Y., M. Deshmukh, A. D' Costa, J.A. Demaro, J.M. Gidday, A. Shah, Y. Sun, M.F. Jacquin, E.M. Johnson, and D.M. Holtzman. 1998. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J. Clin. Invest. 101:1992–1999. - PMC - PubMed

Publication types

MeSH terms